Procter & Gamble (NYSE: PG) reported Q2 EPS of $1.88, $0.01 better than the analyst estimate of $1.87. Revenue for the quarter came in at $21.9 billion versus the consensus estimate of $21.69 billion.

GUIDANCE:

Procter & Gamble sees FY2025 EPS of $6.91-$7.05, versus the consensus of $6.93.

P&G maintained its guidance range for fiscal 2025 all-in sales growth to be in the range of two to four percent versus the prior year. The combined headwinds from foreign exchange and divestitures are expected to negatively impact all-in sales growth by approximately one percentage point. The Company also maintained its outlook for organic sales growth in the range of three to five percent.

For earnings history and earnings-related data on Procter & Gamble (PG) click here.